BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2405600)

  • 21. [Recombinant hematopoietic growth factors in the treatment of various hematologic diseases].
    Pawelski S
    Acta Haematol Pol; 1991; 22(1):186-93. PubMed ID: 1823962
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
    Scadden DT
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):33-7. PubMed ID: 1492232
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
    Greenberg P; Negrin R; Nagler A; Souza L; Donlon T
    Prog Clin Biol Res; 1990; 338():151-61. PubMed ID: 1693211
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
    Hirashima K; Bessho M; Jinnai I
    Contrib Nephrol; 1991; 88():254-65. PubMed ID: 2040187
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aplastic anemia--1989. A half-century later].
    Lozada-Román JA
    Bol Asoc Med P R; 1989 Aug; 81(8):316-20. PubMed ID: 2669771
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):5-9. PubMed ID: 8874763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current developments in the treatment of AIDS].
    Mulder JW
    Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1664-6. PubMed ID: 2477718
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
    Laporte JP; Isnard F; Fenaux P; Woler M; Najman A
    Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189
    [No Abstract]   [Full Text] [Related]  

  • 30. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
    Marsh JC; Ganser A; Stadler M
    Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of cytokines in the therapy of hematologic diseases].
    Neuwirt J; Neuwirtová R; Jelínek J
    Cas Lek Cesk; 1988 Dec; 127(51):1582-6. PubMed ID: 3266737
    [No Abstract]   [Full Text] [Related]  

  • 34. Haematopoietic growth factors and their therapeutic use.
    Wadhwa M; Thorpe R
    Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemopoietic growth factors: a review.
    Rowe JM; Rapoport AP
    J Clin Pharmacol; 1992 Jun; 32(6):486-501. PubMed ID: 1378857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies of granulocyte-macrophage colony stimulating factor.
    Gutterman J
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):52-3. PubMed ID: 3057645
    [No Abstract]   [Full Text] [Related]  

  • 39. G-CSF improves white blood count in preleukemic patients.
    Oncology (Williston Park); 1989 Oct; 3(10):52. PubMed ID: 2484248
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematopoietic growth factors.
    Sieff CA
    J Clin Invest; 1987 Jun; 79(6):1549-57. PubMed ID: 3034976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.